FibriCheck vs ClearRead CT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

FibriCheck

by Qompium nv

ClearRead CT

by RIVERAIN TECHNOLOGIES

AI Verdict

FibriCheck is designed for remote heart rhythm monitoring and arrhythmia detection using smartphone technology, primarily for patient self-monitoring and clinician oversight. In contrast, ClearRead CT is an AI suite that analyzes CT scans to enhance pulmonary nodule detection and coronary artery calcification scoring, mainly assisting radiologists in diagnostic imaging. While both operate within the broader field of Cardiology AI, they address distinct clinical needs and utilize different data modalities.

Choose FibriCheck if…

Choose FibriCheck if you are a patient or healthcare provider seeking a convenient, smartphone-based solution for continuous heart rhythm monitoring and early arrhythmia detection. This tool is ideal for remote patient management, allowing individuals to regularly check for conditions like Atrial Fibrillation using their own device and share results with their care team.

View FibriCheck →

Choose ClearRead CT if…

Choose ClearRead CT if you are a radiologist or pulmonologist aiming to enhance the accuracy and efficiency of pulmonary nodule detection and coronary artery calcification analysis in CT scans. This AI suite is best suited for clinical environments requiring advanced image processing, such as patented vessel suppression and automated nodule tracking, to improve diagnostic confidence and streamline workflow.

View ClearRead CT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	FibriCheck	ClearRead CT
Pricing	Available via subscription for end-users (monthly/yearly) or through licensing agreements for healthcare providers and clinical centers.	Contact for pricing
Deployment	Cloud-based digital application	On-premise (stand-alone server, virtual machine) and Cloud
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FibriCheck

FibriCheck (Tool A) is a smartphone application designed for direct patient use, making it highly accessible and user-friendly for a broad consumer base. ClearRead CT (Tool B), while improving workflow for radiologists, is a specialized tool integrated into complex imaging systems, requiring professional operation within a clinical setting.

Clinical Value

ClearRead CT

ClearRead CT (Tool B) offers quantifiable improvements in diagnostic accuracy, reducing missed actionable pulmonary nodules by 29% and reading times by up to 36% for critical conditions like lung cancer and coronary artery disease. While FibriCheck (Tool A) provides valuable arrhythmia detection for patients, ClearRead CT's impact on improving radiologist performance in complex diagnostic tasks demonstrates a higher clinical value in terms of direct diagnostic improvement and efficiency for life-threatening conditions.

Pricing & Value

FibriCheck

FibriCheck (Tool A) provides transparent, published pricing for both end-users and healthcare providers, allowing for clear cost assessment and budgeting. ClearRead CT (Tool B) requires direct contact with the vendor for pricing details, which hinders immediate value comparison and transparency.

Enterprise Readiness

ClearRead CT

ClearRead CT (Tool B) demonstrates strong enterprise readiness with its seamless PACS integration, vendor-neutral processing, and flexible deployment options (on-premise and cloud), making it highly adaptable to existing radiology workflows in large healthcare systems. FibriCheck (Tool A) is cloud-based and offers licensing, but ClearRead CT's specific integration capabilities for complex imaging environments give it an edge.

Innovation

ClearRead CT

ClearRead CT (Tool B) showcases significant technical innovation with its patented Vessel Suppression (Clear Visual Intelligence) and advanced AI for comprehensive nodule characterization, automated tracking, and CAC scoring from ungated CTs, pushing the boundaries of diagnostic imaging. FibriCheck (Tool A) is innovative in its use of smartphone camera-based PPG for heart rhythm monitoring, but ClearRead CT's specialized, patented technologies for complex image analysis represent a higher degree of technical advancement in its domain.

Support & Docs

Tie

Both FibriCheck (Tool A) and ClearRead CT (Tool B) appear to offer standard support resources, including FAQs, contact options, and user manuals, based on web searches. However, the provided structured facts do not offer sufficient detail to definitively distinguish between the two in terms of the breadth or quality of their support and documentation offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	FibriCheck	ClearRead CT
Name	FibriCheck	ClearRead CT
Description	Medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias using just their smartphone.	FDA-cleared AI suite for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans.
Company	Qompium nv	RIVERAIN TECHNOLOGIES
Primary Functionality	Smartphone camera-based PPG technology for heart rhythm measurement, AI-powered algorithm for arrhythmia detection and analysis, healthcare professional portal for patient monitoring.	Pulmonary Nodule Detection (solid, part-solid, ground glass), Patented Vessel Suppression, Coronary Artery Calcification (CAC) Scoring.
Specialties	Cardiology, Family Medicine, Internal Medicine	Cardiology, Pulmonology, Radiology
Categories	Cardiology AI, Wearables & Remote Monitoring (RPM)	Cardiology AI, Oncology AI, Radiology & Imaging AI

Videos

Demos, reviews, and walkthroughs featuring FibriCheck and ClearRead CT.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems, and what is the depth of that integration?

FibriCheck offers API-based integration into existing EHRs, RPM platforms, and population health systems, allowing patient-generated data to flow into the provider portal and potentially the EHR. ClearRead CT provides seamless PACS integration, exporting DICOM format output, ROI contours, and measurements as overlays or DICOM SC objects, with options for worklist integration and pre-populated reports, and also supports HL-7 integration.

What is the clinical accuracy and sensitivity of each tool's AI algorithms for their respective detections?

FibriCheck's algorithm for AF detection has demonstrated high overall performance, with studies showing accuracy rates around 98.5%, sensitivity of 96.3%, and specificity of 99.3% compared to 12-lead ECG. ClearRead CT has shown improved detection accuracy with a 29% reduction in missed actionable pulmonary nodules and high agreement (0.959) for coronary artery calcification (CAC) scoring on ungated CTs compared to ground truth radiologists.

What is the typical learning curve for physicians and their staff, and what support is available to ensure effective utilization?

FibriCheck is designed for ease of use for both patients and healthcare professionals, with studies indicating high patient satisfaction and ease of installation and use. ClearRead CT integrates into existing PACS workflows, which can reduce reading times and improve efficiency, suggesting a potentially lower learning curve for radiologists as it avoids separate applications.

What is the expected time-to-value for each tool, and what are the key considerations for a successful multi-site rollout?

FibriCheck can be rapidly deployed, with examples of operational setup in one weekend and seamless adoption by thousands of patients across multiple centers, demonstrating quick time-to-value and scalability for multi-site rollouts. ClearRead CT's enterprise-wide capability and vendor-neutral processing, along with its integration into existing PACS, suggest efficient rollout across multiple sites and CT manufacturers.

Can you provide examples of clinical contexts where each tool has demonstrated significant impact or customer references?

FibriCheck has been successfully implemented in primary care for AF screening, post-cardioversion monitoring, and symptom management, demonstrating reduced unnecessary ECGs and Holter monitors, and preventing strokes. ClearRead CT has been adopted by the U.S. Department of Veterans Affairs for lung cancer screening and has shown improved nodule detection and reduced reading times in studies at institutions like the University Hospital of Zurich.